LSA
ATYR

Leonteq Securities AG’s aTyr Pharma ATYR Stock Holding History

Leonteq Securities AG’s Portfolio ATYR Stock Details ATYR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-21,146
Closed -$15.3K – 1532
2025
Q3 		$15.3K Buy
21,146
+18,646
+746% +$84.5K ﹤0.01% 1072
2025
Q2 		$12.7K Hold
2,500
– – ﹤0.01% 1032
2025
Q1 		$7.55K Buy
+2,500
New +$9.12K ﹤0.01% 1071

Other funds holding ATYR

RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Leonteq Securities AG's ATYR Position: Q4 2025 in Review

Leonteq Securities AG sold out of aTyr Pharma (ATYR) in Q4 2025, closing a stake of 21,146 shares — an estimated $15.3K sold.

Leonteq Securities AG first reported a position in ATYR in Q1 2025 and held it in 3 quarters. The position peaked at $15.3K in Q3 2025. 84 funds tracked by Wall St. Rank hold ATYR as of Q4 2025.

  • Leonteq Securities AG reported no remaining aTyr Pharma position as of Q4 2025 after selling out during the quarter.
  • Leonteq Securities AG sold 21,146 aTyr Pharma shares in Q4 2025, an estimated $15.3K.
  • Leonteq Securities AG first reported a position in aTyr Pharma in Q1 2025 and held it in 3 quarters.
  • Leonteq Securities AG's aTyr Pharma position peaked at $15.3K in Q3 2025.
  • 84 funds tracked by Wall St. Rank held aTyr Pharma as of Q4 2025.

Based on Leonteq Securities AG's 13F filing for Q4 2025, filed 6 Feb 2026.